EP 0045955 B1 19830831 - ALKYL AND CYCLOALKYL SUBSTITUTED 2-(2-(2-HYDROXY-3-TERT.-BUTYLAMINO-PROPOXY)-5-ACYLAMINOPHENYL)-1,3,4-OXADIAZOLES, THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
Title (en)
ALKYL AND CYCLOALKYL SUBSTITUTED 2-(2-(2-HYDROXY-3-TERT.-BUTYLAMINO-PROPOXY)-5-ACYLAMINOPHENYL)-1,3,4-OXADIAZOLES, THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
Publication
Application
Priority
DE 3030530 A 19800813
Abstract (en)
[origin: US4409232A] A compound of the formula <IMAGE> (I) wherein R is a straight or branched chain alkyl group having 1 to 17 carbon atoms or a cycloalkyl group having 3 to 6 carbon atoms; as well as the physiologically acceptable acid addition salts thereof. A method of production of the compounds, pharmaceutical compositions containing them, and methods of use are also disclosed. The compounds of the present invention are useful in the treatment of angina pectoris, hypertension, and certain forms of arrhythmia.
IPC 1-7
IPC 8 full level
A61K 31/41 (2006.01); A61K 31/4245 (2006.01); A61P 9/06 (2006.01); A61P 9/08 (2006.01); A61P 9/10 (2006.01); A61P 9/12 (2006.01); C07C 243/38 (2006.01); C07D 271/10 (2006.01)
CPC (source: EP US)
A61P 9/06 (2017.12 - EP); A61P 9/08 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 9/12 (2017.12 - EP); C07C 243/38 (2013.01 - EP US); C07D 271/10 (2013.01 - EP US); C07C 2601/02 (2017.04 - EP US); C07C 2601/14 (2017.04 - EP US)
Designated contracting state (EPC)
AT BE CH DE FR GB IT LI NL SE
DOCDB simple family (publication)
EP 0045955 A1 19820217; EP 0045955 B1 19830831; AT E4541 T1 19830915; AU 7384381 A 19820218; CA 1164870 A 19840403; DE 3030530 A1 19820318; DE 3160821 D1 19831006; JP S5759878 A 19820410; US 4409232 A 19831011
DOCDB simple family (application)
EP 81106178 A 19810807; AT 81106178 T 19810807; AU 7384381 A 19810806; CA 383758 A 19810812; DE 3030530 A 19800813; DE 3160821 T 19810807; JP 12602481 A 19810813; US 29095281 A 19810807